BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12379888)

  • 1. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
    Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
    Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
    Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation.
    Shaw BE; Potter MN; Mayor NP; Pay AL; Smith C; Goldman JM; Prentice HG; Marsh SG; Madrigal JA
    Bone Marrow Transplant; 2003 Jun; 31(11):1001-8. PubMed ID: 12774051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese.
    Morishima Y; Kodera Y; Hirabayashi N; Tanimoto M; Matsuyama T; Horibe K; Ohta H; Mizuno S; Morishita Y; Yamauchi T
    Bone Marrow Transplant; 1995 Feb; 15(2):235-9. PubMed ID: 7773212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
    Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
    Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
    Madrigal A; Shaw BE
    Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
    Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
    Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
    Petersdorf EW; Smith AG; Mickelson EM; Longton GM; Anasetti C; Choo SY; Martin PJ; Hansen JA
    Blood; 1993 Apr; 81(7):1923-32. PubMed ID: 8461476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.
    Varney MD; Lester S; McCluskey J; Gao X; Tait BD
    Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation.
    Shaw BE
    Int J Immunogenet; 2008 Aug; 35(4-5):367-74. PubMed ID: 18976440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
    Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
    Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
    J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DP and allogeneic bone marrow transplantation.
    Moreau P; Cesbron A
    Bone Marrow Transplant; 1994 Jun; 13(6):675-81. PubMed ID: 7920290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
    Hägglund H; Boström L; Remberger M; Ljungman P; Nilsson B; Ringdén O
    Bone Marrow Transplant; 1995 Dec; 16(6):747-53. PubMed ID: 8750264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.